Gastric intestinal metaplasia on routine endoscopic biopsy

被引：28

作者：

Fennerty, MB ^{[1
]}

机构：

[1] Oregon Hlth & Sci Univ, Div Gastroenterol, Portland, OR 97239 USA

来源：

关键词：

D O I：

10.1016/S0016-5085(03)00957-0

中图分类号：

R57 [消化系及腹部疾病];

学科分类号：

摘要：

[No abstract available]

引用

页码：586 / 590

页数：5

共 32 条

[1] Annibale B, 2000, ALIMENT PHARM THERAP, V14, P625
[2] Chemoprevention of gastric dysplasia:: Randomized trial of antioxidant supplements and anti-Helicobacter pylori therapy
Correa, P
Fontham, ETH
Bravo, JC
Bravo, LE
Ruiz, B
Zarama, G
Realpe, JL
Malcom, GT
Li, D
Johnson, WD
Mera, R
[J]. JNCI-JOURNAL OF THE NATIONAL CANCER INSTITUTE, 2000, 92 (23): : 1881 - 1888
[3] Prospects for intervention in gastric carcinogenesis: reversibility of gastric atrophy and intestinal metaplasia
Dixon, MF
[J]. GUT, 2001, 49 (01) : 2 - 4
[4] Fennerty MB, 1995, GI CANCER, V1, P39
[5] FENNERTY MB, 1992, CANCER EPIDEM BIOMAR, V1, P293
[6] FENNERTY MB, 1992, GASTROINTEST ENDOSC, V38, P695
[7] ASSOCIATION BETWEEN INFECTION WITH HELICOBACTER-PYLORI AND RISK OF GASTRIC-CANCER - EVIDENCE FROM A PROSPECTIVE INVESTIGATION
FORMAN, D
NEWELL, DG
FULLERTON, F
YARNELL, JWG
STACEY, AR
WALD, N
SITAS, F
[J]. BRITISH MEDICAL JOURNAL, 1991, 302 (6788) : 1302 - 1305
[8] GUARNER J, 1993, CANCER-AM CANCER SOC, V71, P297, DOI 10.1002/1097-0142(19930115)71:2&lt
[9] 297::AID-CNCR2820710205&gt
[10] 3.0.CO